Skip to search formSkip to main contentSkip to account menu

Recurrent Non-Squamous Non-Small Cell Lung Carcinoma

Known as: Recurrent Non-Squamous Non-Small Cell Lung Cancer 
The reemergence of non-squamous non-small cell lung carcinoma after a period of remission.
National Institutes of Health

Related topics

Related topics

15 relations
ChestEGFR Gene MutationEGFR geneEpithelial Cells

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
Bevacizumab treatment for advanced non-small cell lung cancer: A case report
The safety of Avastin in lung cancer (SAiL) study is a multi-center, open-source, stand-alone study. Patients with untreated… 
2012
2012
Randomized , double-blind multicentre phase III study of bevacizumab in combination with cisplatin and gemcitabine in chemotherapy-naïve patients with advanced or recurrent non-squamous non-small…
  • 2012
  • Corpus ID: 36395743
2009
2009
9170 Safety and efficacy of first-line bevacizumab (Bv) plus chemotherapy in elderly patients (pts) with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): SAiL (MO19390)
2007
2007
6594 POSTER First-line bevacizumab in combination with chemotherapy in the treatment of patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC): an open-label safety study…
2007
2007
6518 ORAL Subgroup results from a randomised, double-blind, multicentre phase III study of bevacizumab in combination with cisplatingemcitabine in chemotherapy-naive patients with advanced or…
2007
2007
6570 POSTER Results for progression-free survival (PFS) from two randomised, double-blind, multicentre phase III studies of bevacizumab in combination with platin-based chemotherapy in patients with…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)